ES2139881T3 - Formulacion acuosa de liberacion retardada. - Google Patents

Formulacion acuosa de liberacion retardada.

Info

Publication number
ES2139881T3
ES2139881T3 ES95906743T ES95906743T ES2139881T3 ES 2139881 T3 ES2139881 T3 ES 2139881T3 ES 95906743 T ES95906743 T ES 95906743T ES 95906743 T ES95906743 T ES 95906743T ES 2139881 T3 ES2139881 T3 ES 2139881T3
Authority
ES
Spain
Prior art keywords
bovine somatotropin
release formulation
delayed release
aqueous
circulatory system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95906743T
Other languages
English (en)
Inventor
Michael J Hageman
Margaret L Possert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of ES2139881T3 publication Critical patent/ES2139881T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LIBERACION PARENTERAL PROLONGADA EN EL SISTEMA CIRCULATORIO DE UNA VACA DE UNA SOMATOTROPINA BOVINA BIOACTIVA EN NIVELES DESEADAMENTE EFICACES QUE SE PUEDE CONSEGUIR UTILIZANDO COMPOSICIONES NUEVAS EN LAS QUE LA SOMATOTROPINA BOVINA SE ENCUENTRA PRESENTE EN UN LIQUIDO ACUOSO EN UNA DOSIS DE LA MENOS APROXIMADAMENTE 150 MG Y EN UNA CONCENTRACION DE AL MENOS APROXIMADAMENTE 50 MG/ML. LA FORMULACION DE SOMATOTROPINA BOVINA ACUOSA PROPORCIONA LA LIBERACION SOSTENIDA DE LA SOMATOTROPINA BOVINA EN EL SISTEMA CIRCULATORIO DEL ANIMAL DURANTE MAS DE TRES (3) DIAS.
ES95906743T 1994-01-25 1995-01-09 Formulacion acuosa de liberacion retardada. Expired - Lifetime ES2139881T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18657294A 1994-01-25 1994-01-25

Publications (1)

Publication Number Publication Date
ES2139881T3 true ES2139881T3 (es) 2000-02-16

Family

ID=22685468

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95906743T Expired - Lifetime ES2139881T3 (es) 1994-01-25 1995-01-09 Formulacion acuosa de liberacion retardada.

Country Status (18)

Country Link
US (2) US6471977B1 (es)
EP (1) EP0741579B1 (es)
JP (1) JPH09508118A (es)
KR (1) KR100355517B1 (es)
CN (1) CN1139385A (es)
AT (1) ATE187077T1 (es)
AU (1) AU699746B2 (es)
CA (1) CA2178610A1 (es)
DE (1) DE69513635T2 (es)
DK (1) DK0741579T3 (es)
ES (1) ES2139881T3 (es)
GR (1) GR3032727T3 (es)
LV (1) LV12627B (es)
MX (1) MX9602943A (es)
NZ (1) NZ278770A (es)
SI (1) SI0741579T1 (es)
WO (1) WO1995019787A1 (es)
ZA (1) ZA949350B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA949350B (en) * 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
WO1997025057A1 (en) * 1996-01-11 1997-07-17 Pharmacia & Upjohn Company Aqueous prolonged release formulation
US7319032B2 (en) * 2004-04-22 2008-01-15 Medtox Non-sugar sweeteners for use in test devices
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4118380A (en) 1977-07-25 1978-10-03 Ayerst, Mckenna & Harrison Limited Decapeptide analogs of somatostatin
US4774091A (en) 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
EP0140255B1 (en) 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Sustained-release injections
US4985404A (en) 1984-10-04 1991-01-15 Monsanto Company Prolonged release of biologically active polypeptides
HU196714B (en) 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
EP0193917A3 (en) 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
AU6073386A (en) * 1985-07-30 1987-02-05 International Minerals & Chemical Corporation Stabilization of growth promoting hormones
US4977140A (en) 1985-08-23 1990-12-11 Eli Lilly And Company Injectable sustained release formulation
US4816568A (en) 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
US4857506A (en) 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
US4888416A (en) 1987-03-30 1989-12-19 International Minerals & Chemical Corp. Method for stabilizing somatotropins
EP0353045B1 (en) 1988-07-26 1995-11-15 Rutgers, The State University of New Jersey Devices and methods for growth promotion in poultry roasters
EP0374120A3 (en) 1988-12-13 1991-07-31 Monsanto Company Comosition for controlled release of polypeptides
US5015627A (en) 1990-07-20 1991-05-14 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
US5169834A (en) 1990-11-30 1992-12-08 American Cyanamid Company Compositions and method for reducing vial breakage during lyophilization
US5198422A (en) 1992-06-11 1993-03-30 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
ZA949350B (en) * 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation

Also Published As

Publication number Publication date
ATE187077T1 (de) 1999-12-15
SI0741579T1 (en) 2000-04-30
CA2178610A1 (en) 1995-07-27
NZ278770A (en) 1997-09-22
EP0741579B1 (en) 1999-12-01
CN1139385A (zh) 1997-01-01
AU699746B2 (en) 1998-12-10
DE69513635T2 (de) 2000-05-31
US6699490B2 (en) 2004-03-02
DK0741579T3 (da) 2000-05-15
LV12627A (lv) 2001-03-20
EP0741579A1 (en) 1996-11-13
KR100355517B1 (ko) 2003-03-04
US6471977B1 (en) 2002-10-29
LV12627B (en) 2001-08-20
MX9602943A (es) 1997-06-28
JPH09508118A (ja) 1997-08-19
GR3032727T3 (en) 2000-06-30
WO1995019787A1 (en) 1995-07-27
US20030092625A1 (en) 2003-05-15
DE69513635D1 (de) 2000-01-05
ZA949350B (en) 1996-05-24
AU1521395A (en) 1995-08-08
US20030220242A9 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
NZ294464A (en) Stable, aqueous formulation having high biological alpha-type interferon activity buffered from 4.5 to 7.1 and comprising chelating agent and a polyoxyethylene sorbitan monooleate, formulation free from human blood-derived products
DK59182A (da) Farmaceutiske midler med kontinuerlig frigoerelse
DK0731699T3 (da) Fremgangsmåde til reduktion af legemsfedt i dyr ved indgivelse af konjugeret linolsyre
FI970298A0 (fi) DHA:n käyttö farmaseuttisena koostumuksena
MY125556A (en) Aqueous formulations of peptide
DE69434418D1 (de) Orale Dareichungsform
AU633714B2 (en) New uses of l-deprenyl and compositions for same
PE20010400A1 (es) Formulacion de sal comun y moxifloxacina
RU98117135A (ru) Композиция стабилизированного гормона роста и способ ее приготовления
EE9900428A (et) Köhavastased ravimkoostised
ES2114851T3 (es) Utilizacion de composiciones de liberacion sostenida que contienen gnrh, lhrh o derivados de las mismas.
UA43335C2 (uk) Препаративна форма у вигляді розчину для обробки тварин, що включає авермектини (варіанти), спосіб одержання і спосіб обробки тварин (варіанти)
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
PT873134E (pt) Formulacao aquosa de libertacao prolongada compreendendo factor de libertacao da hormona do crescimento bovino
ES2139881T3 (es) Formulacion acuosa de liberacion retardada.
GR3029319T3 (en) Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity
EP0236002A3 (en) Pharmaceutical composition comprising a medicament and a water-swellable polymer
EP0539516A4 (es)
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.
ATE97806T1 (de) Fluessige nitrofurantoinsuspension.
RU92015628A (ru) Состав для дезинфекции объектов пчеловодства
BG49848A1 (en) Cytocinine means

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 741579

Country of ref document: ES